Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay

Annals of Surgical Oncology

Volumn 17, Issue 12, 2010, Pages 3370-3378

  Esemuede, Iyare ^a   Forslund, Ann ^b   Khan, Sajid A ^a   Qin, Li Xuan ^a   Gimbel, Mark I ^a   Nash, Garrett M ^a   Zeng, Zhaoshi ^a   Rosenberg, Shoshana ^a   Shia, Jinru ^a   Barany, Francis ^c   Paty, Philip B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; K RAS PROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CHROMOSOME LOSS; CLINICAL ARTICLE; CLINICAL EVALUATION; CODON; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTERMETHOD COMPARISON; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PROGNOSIS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA REPAIR; DNA REPAIR ENZYMES; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; LYMPHATIC METASTASIS; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78650989829     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1147-4     Document Type: Article

References (23)

1. GM Nash M Gimbel J Shia AT Culliford DR Nathanson M Ndubuisi, et al. 2003 Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer J Clin Oncol 21 3105 3112 1:CAS:528:DC%2BD2cXpsVWqtLc%3D 10.1200/JCO.2003.11.133 12915601 (Pubitemid 46606291)
2. R Gryfe 2006 Clinical implications of our advancing knowledge of colorectal cancer genetics: Inherited syndromes, prognosis, prevention, screening and therapeutics Surg Clin N Am 86 787 817 10.1016/j.suc.2006.05.007 16905411 (Pubitemid 44189474)
3. FA Sinicrope RL Rego KC Halling N Foster DJ Sargent B La Plant, et al. 2006 Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients Gastroenterology 131 729 737 1:CAS:528: DC%2BD28XhtVKrurjK 10.1053/j.gastro.2006.06.005 16952542 (Pubitemid 44307064)
4. L Laghi P Bianchi A Malesci 2008 Differences and evolution of the methods for the assessment of microsatellite instability Oncogene 27 6313 6321 1:CAS:528:DC%2BD1cXht1Ont7bE 10.1038/onc.2008.217 18679418
5. O'Dwyer PJ. Oxaliplatin, leucovorin, and fluorouracil with or without bevacizumab in treating patients who have undergone surgery for stage II colon cancer; 2008. Available: http://www.clinicaltrials.gov. Accessed 12 February 2009.
6. W-S Jo JM Carethers 2006 Chemotherapeutic implications in microsatellite unstable colorectal cancer Cancer Biomark 2 51 60 1:CAS:528:DC%2BD28XovFWltrg%3D 17192059
7. GP Kim LH Colangelo HS Wieand S Paik IR Kirsch N Wolmark, et al. 2007 Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study J Clin Oncol 25 767 772 1:CAS:528: DC%2BD2sXjvVKmt7s%3D 10.1200/JCO.2006.05.8172 17228023 (Pubitemid 350002875)
8. JT Liang KC Huang HS Lai PH Lee YM Cheng HC Hsu, et al. 2002 High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection Int J Cancer 101 519 525 1:CAS:528:DC%2BD38Xns1eru7k%3D 10.1002/ijc.10643 12237891
9. CR Boland SN Thibodeau SR Hamilton D Sidransky JR Eshleman RW Burt, et al. 1998 A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 5248 5257 1:CAS:528:DyaK1cXnsFSmtbk%3D 9823339
10. N Suraweera A Duval M Reperant C Vaury D Furlan K Leroy, et al. 2002 Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR Gastroenterology 123 1804 1811 1:CAS:528:DC%2BD38Xps1yktb8%3D 10.1053/gast.2002.37070 12454837 (Pubitemid 35408304)
11. RM Xicola X Llor E Pons A Castells C Alenda V Pinol, et al. 2007 Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors J Natl Cancer Inst. 99 244 252 1:CAS:528:DC%2BD2sXis1ShtbY%3D 10.1093/jnci/djk033 17284719
12. A Umar CR Boland JP Terdiman S Syngal A de la Chapelle J Ruschoff, et al. 2004 Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 261 268 1:CAS:528:DC%2BD2cXhsV2qtLk%3D 10.1093/jnci/djh034 14970275 (Pubitemid 38256271)
13. JR Shia 2008 Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry J Mol Diagn 10 301 307 10.2353/jmoldx.2008.080031 (Pubitemid 352019113)
14. J Alexander 2001 Histopathological identification of colon cancer with microsatellite instability Am J Pathol 158 527 535 1:STN:280: DC%2BD3M7psVerug%3D%3D 11159189
15. R Ward A Meagher I Tomlinson T O'Connor M Norrie R Wu, et al. 2001 Microsatellite instability and the clinicopathological features of sporadic colorectal cancer Gut 48 821 829 1:STN:280:DC%2BD3M3msl2isA%3D%3D 10.1136/gut.48.6.821 11358903 (Pubitemid 32476985)
16. M Guidoboni R Gafà A Viel C Doglioni A Russo A Santini, et al. 2001 Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis Am J Pathol 159 297 304 1:STN:280:DC%2BD3Mzpt1arsQ%3D%3D 11438476
17. P Peterlongo K Nafa GS Lerman E Glogowski J Shia TZ Ye, et al. 2003 MSH6 germline mutations are rare in colorectal cancer families Int J Cancer. 107 571 579 1:CAS:528:DC%2BD3sXoslequ7c%3D 10.1002/ijc.11415 14520694 (Pubitemid 37296117)
18. M Khanna W Cao M Zirvi P Paty F Barany 1999 Ligase detection reaction for identification of low abundance mutations Clin Biochem 32 287 290 1:CAS:528:DyaK1MXlslehtrY%3D 10.1016/S0009-9120(99)00020-X 10463822 (Pubitemid 29385661)
19. ZS Zeng MR Weiser E Kuntz CT Chen SA Khan A Forslund, et al. 2008 c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases Cancer Lett 265 258 269 1:CAS:528:DC%2BD1cXmtlWhsbw%3D 10.1016/j.canlet.2008.02.049 18395971
20. H Hampel WL Frankel E Martin M Arnold K Khanduja P Kuebler, et al. 2008 Feasibility of screening for Lynch syndrome among patients with colorectal cancer J Clin Oncol 26 5783 5788 10.1200/JCO.2008.17.5950 18809606
21. LS Li NG Kim SH Kim C Park H Kim HJ Kang, et al. 2003 Chromosomal Imbalances in the Colorectal Carcinomas with Microsatellite Instability Am J Pathol 163 1429 1436 1:CAS:528:DC%2BD3sXotlegtrY%3D 14507650
22. K Trautmann JP Terdiman AJ French R Roydasgupta N Sein S Kakar, et al. 2006 Chromosomal instability in microsatellite-unstable and stable colon cancer Clin Cancer Res 12 6379 6385 1:CAS:528:DC%2BD28XhtFKitb7L 10.1158/1078-0432.CCR- 06-1248 17085649 (Pubitemid 44799708)
23. LA Aaltonen R Salovaara P Kristo F Canzian A Hemminki P Peltomaki, et al. 1998 Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease N Engl J Med 338 1481 1487 1:STN:280:DyaK1c3kt12ktQ%3D%3D 10.1056/NEJM199805213382101 9593786 (Pubitemid 28226275)